News | April 27, 2015

HealthMyne Inc. Receives NSF Grant for Novel Oncology Imaging Analytics Platform

Startup’s first commercial product will target lung cancer screening

April 27, 2015 — HealthMyne Inc. received a Phase II Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF). The grant is for almost $750,000, with a potential to receive an additional $500,000 in Phase IIB funding.

“The overall thrust of our proposal centers on treating the visible evidence of cancer in medical images, not just as pictures, but as mineable data that can be compared across similar cases,” stated Roger Chylla, Ph.D., chief technology officer of HealthMyne and the project’s principal investigator. “Clinical research over the last decade has demonstrated that nodules (early-stage tumors) have reproducible features linked to the probability that they are malignant and/or resistant to certain treatments. For patient care to be improved by these insights, doctors need clinical tools that seamlessly incorporate this evidence into their everyday image interpretation.”

HealthMyne’s first commercial product will be targeting lung cancer screening. Lung cancer causes more deaths in the United States than the next three most common cancers combined; however, studies have shown that the associated mortality rate can significantly improve when detected early.

This specific award was the second phase of a grant submitted as part of NSF’s efforts to foster smart health technologies. According to Jesus Soriano, M.D., Ph.D., program director of SBIR/STTR at NSF, “These categorical proposals must demonstrate an ability to transform healthcare from reactive, hospital-centered, and indemnity-based to proactive, person-centered, preventive, and cost-efficient.”

At the National Science Foundation (NSF), Small Business Innovation Research/Small Business Technology Transfer (SBIR/STTR) is an approximately $160 million program that catalyzes the commercialization of high-risk technological innovations via research and development grants to small businesses and startups.

For more information: www.healthmyne.com

Related Content

3-D Reconstruction of Ichthyosaurus Skull

A 3-D reconstruction of the ichthyosaurus skull from a computed tomography (CT) scan. Image courtesy of Nigel Larkin, taken at Royal Veterinary College, London.

News | Computed Tomography (CT) | January 09, 2019
A nearly meter-long skull of a giant fossil marine ichthyosaur found in a farmer's field more than 60 years ago has...
SCCT Releases New Guideline for CT Use During TAVR
News | Computed Tomography (CT) | January 08, 2019
The Society of Cardiovascular Computed Tomography (SCCT) has released a new expert consensus document for computed...
Artificial Intelligence Pinpoints Nine Different Abnormalities in Head Scans

A brain scan (left) showing an intraparenchymal hemorrhage in left frontal region and a scan (right) of a subarachnoid hemorrhage in the left parietal region. Both conditions were accurately detected by the Qure.ai tool. Image courtesy of Nature Medicine.

News | Artificial Intelligence | January 07, 2019
The rise in the use of computed tomography (CT) scans in U.S. emergency rooms has been a well-documented trend1 in...
CT Technique Expands Possibilities of Imaging Ancient Remains
News | Computed Tomography (CT) | December 27, 2018
Researchers in Sweden using computed tomography (CT) have successfully imaged the soft tissue of an ancient Egyptian...
Canon Aquilion One CT Helps Gates Vascular Institute Adhere to New Stroke Guidelines
News | Computed Tomography (CT) | December 12, 2018
In stroke, time saved on imaging is time gained in the treatment window. The recently updated guidelines from the...
Coreline Soft Introduces AI Lung Segmentation Solution at RSNA 2018
News | Lung Cancer | December 10, 2018
December 10, 2018 — Korean image software company Coreline Soft Co. Ltd.
FDA Approves New Features for Planmed Verity Cone Beam CT Scanner
Technology | Computed Tomography (CT) | December 07, 2018
The U.S. Food and Drug Administration (FDA) issued an approval letter for the new features and intended uses of the...
YITU Releases AI-Based Cancer Screening Solutions at RSNA 2018
News | Artificial Intelligence | December 06, 2018
Chinese artificial intelligence (AI) healthcare company YITU healthcare released two brand-new products, Intelligent...
Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...
GE Healthcare Unveils New Applications and Smart Devices Built on Edison Platform
Technology | Artificial Intelligence | December 05, 2018
GE Healthcare recently announced new applications and smart devices built on Edison – a platform that helps accelerate...